![Mary Szela](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Szela
Directeur Général chez
TRISALUS LIFE SCIENCES, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Mary T.
Szela is President, Chief Executive Officer & Director at TriSalus Operating Life Sciences, Inc. and TriSalus Life Sciences, Inc. since 2018.
Ms. Szela serves as Independent Director at Kura Oncology, Inc. since 2018, Director at Absci Corp.
since 2025, Independent Director at Averin Capital Acquisition Corp.
since 2026, Director at Court Appointed Special Advocates of Lake County, and Director at Sail Biomedicines Inc. Former roles include Chief Executive Officer & Director at Aegerion Pharmaceuticals, Inc. in 2016, Chief Executive Officer & Director at Novelion Therapeutics, Inc. from 2016 to 2017, Co-Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2013 to 2015, Independent Director at Novo Nordisk A from 2014 to 2017, Independent Director at Receptos LLC from 2014 to 2015, Director at Zikani Therapeutics, Inc. from 2018 to 2019, Director at Suneva Medical, Inc. from 2012 to 2017, Independent Director at Coherus Oncology, Inc. from 2014 to 2021, Independent Director at Prometheus Biosciences, Inc. from 2021 to 2023, Independent Director at Alimera Sciences, Inc. from 2018 to 2021, Independent Director at Omega Therapeutics, Inc. from 2019 to 2025, SVP-Global Strategic Marketing & Services at Abbott Laboratories from 2010 to 2012, and Senior Vice President at US Pharmaceuticals, Inc. from 2008 to 2009.
Education includes undergraduate and MBAistration degrees from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2026 | 1 065 215 ( 1,73 % ) | 4 M $ | 31/05/2026 | |
ABSCI CORPORATION 0,01 % | 04/06/2026 | 8 400 ( 0,01 % ) | 56 700 $ | 31/05/2026 |
KURA ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mary Szela
| Sociétés | Poste | Début |
|---|---|---|
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 06/11/2018 |
| TRISALUS LIFE SCIENCES, INC. | Directeur Général | 01/01/2018 |
| ABSCI CORPORATION | Directeur/Membre du Conseil | 07/07/2025 |
Sail Biomedicines
 Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Directeur/Membre du Conseil | - |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Directeur Général | 23/01/2018 |
Court Appointed Special Advocates of Lake County
 Court Appointed Special Advocates of Lake County Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Directeur/Membre du Conseil | - |
Anciens postes connus de Mary Szela
| Sociétés | Poste | Fin |
|---|---|---|
| OMEA THER | Directeur/Membre du Conseil | 01/01/2025 |
| PROMETHEUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 16/06/2023 |
| COHERUS ONCOLOGY, INC. | Directeur/Membre du Conseil | 05/08/2021 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mary Szela
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Health Technology |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Court Appointed Special Advocates of Lake County
Court Appointed Special Advocates of Lake County Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Commercial Services |
Absci Corp.
 Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Health Technology |
